Chimeric antigen receptor (CAR+) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC).
Susan F. Slovin
No relevant relationships to disclose
Xiuyan Wang
No relevant relationships to disclose
Melanie Hullings
No relevant relationships to disclose
Gabrielle Arauz
No relevant relationships to disclose
Shirley Bartido
No relevant relationships to disclose
Jason Stuart Lewis
No relevant relationships to disclose
Heiko Schöder
No relevant relationships to disclose
Pat Zanzonico
No relevant relationships to disclose
Howard I. Scher
No relevant relationships to disclose
Isabelle Riviere
No relevant relationships to disclose